Biosimilar trastuzumab and rituximab on the PBS - information for health professionals and patients

Page last updated: 2 January 2020

New biosimilar brands of trastuzumab (Ontruzant®) and rituximab (Truxima®) have listed on the PBS on 1 January 2020. Information about these listings for health professionals and patients can be found on the Biosimilar Awareness Initiative web page. Further information about biosimilar uptake drivers applied to rituximab is also available on the ‘Biosimilars on the PBS’ webpage of this website.